# Carmot Therapeutics Inc. — Form D

Carmot Therapeutics Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-06. The offering totals $150.0M, of which $150.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-06-06
- Form: D
- Accession: 0001490109-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $150.0M
- Amount sold: $150.0M
- Investors: 25
- Date of first sale: 2023-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-483450

## Issuer

- Name: Carmot Therapeutics Inc.
- CIK: 0001490109
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 409 ILLINOIS STREET, SAN FRANCISCO, CA, 94158
- Phone: 510-828-0102

## Officers, directors & promoters (22)

| Name | Role | Location |
| --- | --- | --- |
| Timothy K Garnett | Director | Berkeley, CA |
| Stig K Hansen, Ph.D. | Director | Berkeley, CA |
| Tim K Kutzkey | Director | Berkeley, CA |
| Anne K Phillips, M.D. | Director | Berkeley, CA |
| Peter K Svennilson | Director | Berkeley, CA |
| Aetna Wun K Trombley | Director | Berkeley, CA |
| Heather K Turner | Director | Berkeley, CA |
| Heather K Turner | Executive Officer | Berkeley, CA |
| Stig K Hansen | Director | Berkeley, CA |
| Stig K Hansen | Executive Officer | Berkeley, CA |
| Tim K Kutzky | Director | Berkeley, CA |
| Daniel A Erlanson | Director | San Francisco, CA |
| Daniel A Erlanson | Executive Officer | San Francisco, CA |
| Aetna Wun Trombley | Director | San Francisco, CA |
| Larry K Lasky | Director | San Francisco, CA |
| Magnus K Persson | Director | San Francisco, CA |
| Stig K. Hansen | Director | San Francisco, CA |
| Stig K. Hansen | Executive Officer | San Francisco, CA |
| Dave K. Goeddel | Director | San Francisco, CA |
| Daniel A. Erlanson | Director | San Francisco, CA |
| Daniel A. Erlanson | Executive Officer | San Francisco, CA |
| Tim K. Kutzkey | Director | San Francisco, CA |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-08-08](https://search.stillhousedata.com/formd/0001490109-22-000002) | D | $160.7M | $160.7M |
| [2020-10-01](https://search.stillhousedata.com/formd/0001490109-20-000001) | D | $46.9M | $26.3M |
| [2017-08-25](https://search.stillhousedata.com/formd/0001490109-17-000001) | D | $15.4M | $10.8M |
| [2012-07-17](https://search.stillhousedata.com/formd/0001490109-12-000001) | D | $1.2M | $500K |
| [2010-04-23](https://search.stillhousedata.com/formd/0001490109-10-000001) | D | $1.5M | $1.5M |

## More

- [CIK 1490109 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1490109&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001490109-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.